Linkage and association studies of schizophrenia

Current Psychiatry Reports

Volumn 5, Issue 2, 2003, Pages 121-127

  McGuffin, Peter ^a   Tandon, Kopal ^b   Corsico, Alejandro ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CATECHOL METHYLTRANSFERASE; DYSBINDIN; DYSTROBREVIN; GENE PRODUCT; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; NOTCH RECEPTOR; PROLINE DEHYDROGENASE; PROTEIN G72; UNCLASSIFIED DRUG; CARRIER PROTEIN; DTNBP1 PROTEIN, HUMAN;

CHROMOSOME 13Q; CHROMOSOME 22Q; CHROMOSOME 6P; CHROMOSOME 8P; GENE DELETION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; HERITABILITY; HUMAN; HUMAN GENOME; NONHUMAN; REVIEW; SCHIZOPHRENIA; CHROMOSOME 13; CHROMOSOME 22; CHROMOSOME 8; CHROMOSOME MAP; GENETICS; METHODOLOGY;

CARRIER PROTEINS; CATECHOL O-METHYLTRANSFERASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; LINKAGE (GENETICS); NEUREGULIN-1; PROLINE OXIDASE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0142259344     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0028-y     Document Type: Review

References (50)

1. Cardno AG, Gottesman H: Twin studies of schizophrenia: from bow-and-arrow concordances to Star Wars Mx and functional genomics. Am J Med Genet 2000, 97:12-17.
2. Farmer AE, McGuffin P, Gottesman H: Twin concordance for DSM-III schizophrenia.: scrutinizing the validity of the definition. Arch Gen Psychiatry 1987, 44:634-641.
3. McGuffin P, Sturt E: Genetic markers in schizophrenia. Hum Hered 1986, 36:65-88.
4. The International Human Genome Mapping Consortium: Initial sequencing and analysis of the human genome. Nature 2000, 409:860-921.
5. Sham P, McGuffin P: Linkage and association. In Psychiatric Genetics and Genomics. Edited by McGuffin P, Owen MJ, Gottesman H. Oxford: Oxford University Press; 2002:55-73.
6. Liddell MB, Williams J, Owen MJ: The dementias. In Psychiatric Genetics and Genomics. Edited by McGuffin P, Owen MJ, Gottesman H. Oxford: Oxford University Press; 2002:341-396.
7. Thomson G: Significance levels in genome scans. Adv Genet 2001, 42:475-486.
8. Riley BP, McGuffin P: Linkage and associated studies of schizophrenia. Am J Med Genet 2000, 97:23-44.
9. Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241-247.
10. Brzustowicz LM, Hodgkinson KA, Chow EW, et al.: Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000, 288:678-682.
11. Gurling HM, Kalsi G, Brynjolfson J, et al.: Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 2001, 68:661-673.
12. Levinson DF, Holmans PA, Laurent C, et al.: No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002, 296:739-741.
13. Blackwood DH, Visscher PM, Muir WJ: Genetic studies of bipolar affective disorder in large families. Br J Psychiatry 2001, 41:134-136.
14. Hovatta I, Varilo T, Suvisaari J, et al.: A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999, 65:1114-1124.
15. Ekelund J, Lichtermann D, Hovatta I, et al.: Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 2000, 9:1049-1057.
16. Owen MJ, O'Donovan MC, Gottesman H: Schizophrenia. In Psychiatric Genetics and Genomics. Edited by McGuffin P, Owen MJ, Gottesman H. Oxford: Oxford University Press; 2002:247-266.
17. Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940-945.
18. Badner JA, Gershon ES: Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405-411.
19. Suarez BK, Hamper CL, Van Eeerdewegh P: Problems of replivating linkage claims in psychiatry. In Genetic Approaches to Mental Disorders. Edited by Gershon ES, Cloninger CR. Washington DC; American Psychiatric Press: 1994.
20. Baron M: Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Genet 2001, 68:299-312.
21. Polesskaya OO, Sokolov BP: Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002, 67:812-822.
22. Williams J, McGuffin P, Nothen M, Owen MJ: Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 1997, 349:1221.
23. Chen RY, Sham P, Chen EY, et al.: No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res 2001, 105:175-185.
24. Haider MZ, Zahid MA: No evidence for an association between the 5-hydroxytryptamine 5-HT2a receptor gene and schizophrenia in Kuwaiti Arabs. Psychiatry Clin Neurosci 2002, 56:465-467.
25. Williams J, Spurlock G, Holmans P, et al.: A meta-analysis and transmission dysequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998, 3:141-149.
26. Anney RJ, Rees MI, Bryan E, et al.: Characterization, mutation detection, and association analysis of alternative promoters and 5′ UTRs of the human dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 2002, 7:493-502.
27. Williams NM, Bowen T, Spurlock G, et al.: Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Mol Psychiatry 2002, 7:508-514.
28. Begni S, Popoli M, Moraschi S, et al.: Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and schizophrenia. Mol Psychiatry 2002, 7:416-418.
29. Devon RS, Anderson S, Teague PW, et al.: The genomic organization of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol Psychiatry 2001, 6:311-314.
30. Wei J, Hemmings GP: The NOTCH4 focus is associated with susceptibility to schizophrenia. Nat Genet 2000, 25:376-377.
31. Ujike H, Yamamoto A, Tanaka Y, et al.: Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder. Psychiatry Res 2001, 101:203-207.
32. Sklar P, Schwab SG, Williams NM, et al.: Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nat Genet 2001, 28:126-128.
33. Fan JB, Tang JX, Gu NF, et al.: A family-based and case-control association study of the NOTCH4 gene and schizophrenia. Mol Psychiatry 2002, 7:100-103.
34. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al.: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71:877-892.
35. Stefansson H, Sarginson J, Kong A, et al.: Association of neuregulin-1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003, 72:83-87.
36. Chumakov I, Blumenfeld M, Guerassimenko O, et al.: Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002, 99:13675-13680.
37. Straub RE, Jiang Y, MacLean CJ, et al.: Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002, 71:337-348.
38. Liu H, Heath SC, Sobin C, et al.: Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A 2002, 99:3717-3722.
39. Jacquet H, Raux G, Thibaut F, et al.: PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet 2002, 11:2243-2249.
40. Lachman HM, Papolos DF, Saito T, et al.: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
41. Li T, Sham PC, Vallada H, Xie T: Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet 1996, 6:131-133.
42. Kunugi H, Vallada HP, Sham PC, et al.: Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 1997, 7:97-101.
43. Egan MF, Goldberg TE, Kolachana BS, et al.: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
44. Daniels JK, Williams NM, Williams J, et al.: No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. Am J Psychiatry 1996, 153:268-270.
45. Chen EY, Lam LC, Chen RY, et al.: Neuropsychological correlates of sustained attention in schizophrenia. Schizophr Res 1997, 24:299-310.
46. Strous RD, Bark N, Woerner M, Lachman HM: Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 1997, 41:493-495.
47. Norton N, Kirov G, Zammit S, et al.: Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet 2002, 114:491-496.
48. Ohmori O, Shinkai T, Kojima H, et al.: Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 1998, 243:109-112.
49. Shifman S, Bronstein M, Sternfeld M, et al.: A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002, 71:1296-1302.
50. Moises HW, Zoega T, Gottesman H: The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002, 2:8.